DDInter948 DDInter694
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD
A second-line antitubercular agent that inhibits mycolic acid synthesis. It also may be used for treatment of leprosy. (From Smith and Reynard, Textbook of Pharmacology, 1992, p868)
Ethionamide {u} (Compound) upregulates {v} (Gene) ZNF586
Ethionamide {u} (Compound) downregulates {v} (Gene) ZDHHC6
Ethionamide {u} (Compound) causes {v} (Side Effect) Dermatitis
Ethionamide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Clofarabine
Ethionamide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Etanercept
Ethionamide {u} may lead to a major life threatening interaction when taken with {v} Teriflunomide
Ethionamide (Compound) upregulates ZNF586 (Gene)
Ethionamide (Compound) downregulates ZDHHC6 (Gene)
Ethionamide (Compound) causes Dermatitis (Side Effect)
Ethionamide may cause a moderate interaction that could exacerbate diseases when taken with Clofarabine
Ethionamide may cause a moderate interaction that could exacerbate diseases when taken with Etanercept
Ethionamide may lead to a major life threatening interaction when taken with Teriflunomide